Enhanced adherence support

BEHAVIORAL3 trials

Sponsors

Centre for the AIDS Programme of Research in South Africa, National Institute of Allergy and Infectious Diseases (NIAID), Childrens Investment Fund Foundation

Conditions

HIV InfectionsHIV/AIDS

Phase 2

Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum

CompletedNCT03386578

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2018-07-03End: 2024-02-24Updated: 2025-02-19

Phase 3

An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)

CompletedNCT00408642

Centre for the AIDS Programme of Research in South AfricaHIV Infections

Start: 2007-08-31End: 2011-03-31Updated: 2016-02-01

Phase 4

The PrEDIRA Study

RecruitingPACTR202109545700165

Childrens Investment Fund FoundationHIV/AIDS

Start: 2021-09-13Target: 400Updated: 2026-01-27

Related Papers

Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa

Clinical Infectious Diseases2020-12-1761 citations